Correspondence 0000950103-23-004486 from ADC Therapeutics SA (ADCT)

ADC Therapeutics SA
Date: March 21, 2023 · CIK: 0001771910 · Accession: 0000950103-23-004486

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-270570

Date

March 21, 2023

Author

ADC Therapeutics SA

Form

CORRESP

Company

ADC Therapeutics SA

Letter

Re: ADC Therapeutics SA

March 21, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Registration Statement on Form F-3

Registration No. 333-270570

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form F-3 (File No. 333-270570) (the “Registration Statement”) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:30 p.m., Eastern time, on March 24, 2023, or as soon as practicable thereafter.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.

Thank you for your assistance in this matter.

Sincerely,
ADC Therapeutics SA

Show Raw Text

CORRESP
1
filename1.htm

    March 21, 2023

    VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

    Re:
    ADC Therapeutics SA

Registration Statement on Form F-3

Registration No. 333-270570

In accordance with Rule 461 under the Securities Act of 1933, as amended,
we hereby request acceleration of the effective date of the Registration Statement on Form F-3 (File No. 333-270570) (the “Registration
Statement”) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:30 p.m.,
Eastern time, on March 24, 2023, or as soon as practicable thereafter.

Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.

Thank you for your assistance in this matter.

Sincerely,

    ADC Therapeutics SA

    By:
    /s/ Peter J. Graham

    Name:
    Peter J. Graham

    Title:
    Chief Legal Officer

SecProbe.io